IMUX: Immunic Inc O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Immunic, Inc. (IMUX) psoriaz va sklerozni davolash uchun oral DHODH ingibitorlarini ishlab chiqishga e'tibor qaratadi. Hisoblangan PEG koeffitsiyenti foydaga nisbatan kapitalizatsiya dinamikasini aks ettiradi, bunda 0.00 belgisi asosiy ko'rsatkich vazifasini o'taydi. Molekulalar uchun patent himoyasi monopoliyani va premium narxlarni ta'minlaydi, innovatsion terapiyaga bo'lgan noelastik talab esa kelajakda kompaniya uchun sezarli narx belgilash imkoniyatini yaratadi.
Immunic, Inc. (IMUX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Immunic, Inc.|IMUX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi immunic-therapeutics.com|IMUX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Immunic Inc|IMUX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Immunic|Tezkor likvidlik ko‘rsatkichi immunic-therapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
IMUX - Kompaniyaning sof foydasi|Kelajakdagi foyda Immunic, Inc.|IMUX - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori immunic-therapeutics.com|IMUX - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Immunic Inc|IMUX - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Immunic|IMUX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi immunic-therapeutics.com|IMUX - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Immunic, Inc.
Kompaniyaning umumiy tahlili:IMUX - Immunic Therapeutics
Fundamental aktivlarni saralash spekulyativ shovqinlarni biznesning real salohiyatidan ajratishni talab qiladi. Ushbu ko'rsatkich P/E koeffitsientini foyda o'sish sur'atlari bilan solishtiradi va qiymat birdan pastga tushganda aktivning qadrsizlanganini aniqlaydi. P/E multiplikatori va o'sish o'rtasidagi muvozanatni tahlil qilish orqali investor joriy aksiya narxining asoslanganligini aniqlaydi. Immunic, Inc. (IMUX) uchun bunday metrika noyob dori vositalarining ishlab chiqilishi tufayli juda muhimdir. Innovatsiyalarning patent himoyasi skleroz terapiyasida monopoliyani ta'minlaydi va narxlarni belgilash imkoniyatini beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Pharvaris Pharma PHVS|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori tourmalinebio.com|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Narx-foyda va o‘sish multiplikatori Pharming Group NV (PHAR)|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|PEG multiplikatori Upstream Pharma (UPB)|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Gossamer Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharma KALV|SEPN: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Pieris Corp|Narx-foyda va o‘sish multiplikatori SVRA|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Astria Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|RAPT: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Aerovate - PEG multiplikatori|aclaristx.com (ACRS) - Narx-foyda va o‘sish multiplikatori|KYTX (Kyverna Therapeutics, Inc.) - Narx-foyda va o‘sish multiplikatori|TLSA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Theratechnologies Inc. (THTX)|Narx-foyda va o‘sish multiplikatori avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Agenus, Inc. AGEN|CLYM: Narx-foyda va o‘sish multiplikatori|ZURA (zurabio.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|aTyr Pharma, Inc. (ATYR) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ADAG (Adagene Inc.)|IMA (ImageneBio) - PEG multiplikatori|STTK: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori EQ|PEG multiplikatori connectbiopharm.com (CNTB)|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IFRX|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|Adicet Bio (ACET) - Narx-foyda va o‘sish multiplikatori|CELU: PEG multiplikatori|INmune Bio Corporation (INMB) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori BRNS|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SABS|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Akari Therapeutics PLC|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB - Narx-foyda va o‘sish multiplikatori|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|edesabiotech.com (EDSA) - Narx-foyda va o‘sish multiplikatori|IBIO (iBio) - Narx-foyda va o‘sish multiplikatori|Carisma Therapeutics Inc. (CARM) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BOLT (Bolt Bio)|PEG multiplikatori HCWB|APVO - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori AIM (AIM ImmunoTech)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aditxt Inc. (ADTX)|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narx-foyda va o‘sish multiplikatori INDP|PEG multiplikatori Scinai Immunotherapeutics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|affimed.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ALLK (Allakos)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati HOOKIPA Pharma, Inc. (HOOK)|IGM Bio - PEG multiplikatori|iTeos Therapeutics Inc (ITOS) - Narx-foyda va o‘sish multiplikatori|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TC BioPharm Ltd - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|THRD (Third Harmonic Bio) - PEG multiplikatori
